As of 2024-12-13, the Fair Value of ALX Oncology Holdings Inc (ALXO) is -14.33 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 1.42 USD, the upside of ALX Oncology Holdings Inc is -1,109.20%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 5Y Avg | |
| Net income | -19.24 | -45.74 | -83.46 | -123.48 | -160.81 | -86.54 |
| YoY growth | -40.13% | -137.73% | -82.47% | -47.95% | -30.23% | -67.70% |
| Market Cap (mil) | 74.89 |
| P/E | |
| Forward P/E |
| EPS | -2.87 |
| Avg earnings growth rate | -67.70% |
| TTM earnings | -151.16 |